VIVUS, Inc. (NASDAQ:VVUS)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

Recs

0
Player Avatar randomtask16 (78.65) Submitted: 10/21/2010 8:36:34 PM : Underperform Start Price: $5.87 VVUS Score: -307.25

The FDA has proven to be hesitant toward diet drugs.

Featured Broker Partners


Advertisement